Predictive value of cytokines and immune activation biomarkers in AIDS-related non-Hodgkin lymphoma treated with rituximab plus infusional EPOCH (AMC-034 trial)

PURPOSE: The aims of this study were to determine if pre-treatment plasma levels of cytokines and immune activation-associated molecules changed following treatment for AIDS-NHL with rituximab plus infusional EPOCH, and to determine if pre-treatment levels of these molecules were associated with res...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Cancer Res
Main Authors: Epeldegui, Marta, Lee, Jeannette Y., Martínez, Anna C., Widney, Daniel P., Magpantay, Larry I., Regidor, Deborah, Mitsuyasu, Ronald, Sparano, Joseph A., Ambinder, Richard F., Martínez-Maza, Otoniel
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4715998/
https://ncbi.nlm.nih.gov/pubmed/26384320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-0466
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki